Supplements and Canagliflozin.
Canagliflozin, sold under the brand name Invokana, is a sodium-glucose cotransporter 2 (SGLT2) inhibitor: it lowers blood glucose by increasing urinary glucose excretion.
Canagliflozin is an SGLT2 inhibitor. The full name is sodium glucose cotransporter 2. The class lowers blood glucose by increasing urinary glucose excretion. It also carries a separate cardiovascular and renal benefit shown in DAPA-HF, EMPA-REG, and the CKD trials, leading to expanded indication in heart failure and CKD even without diabetes. The supplement surface is small because SGLT2 inhibitors are minimally CYP metabolised. The clinically important issues are urinary tract and genital fungal infections (since glucose in the urine creates favourable conditions), volume depletion in heat or illness (the diuretic effect adds to dehydration risk), and the rare diabetic ketoacidosis presentation including the unusual "euglycaemic" form. Cranberry supplementation often comes up for UTI prevention. The Cochrane evidence supports modest efficacy in recurrent UTI in women. SGLT2 inhibitors tend to RAISE serum magnesium slightly, which is a class effect confirmed in meta-analyses (PMID 35582188, PMID 27628105) and the opposite of what is often assumed. They have even been studied in refractory hypomagnesaemia. Routine magnesium supplementation is not indicated simply because someone takes this drug.
We have not yet completed an explicit assessment of supplement interactions with Canagliflozin in the Distil database. That is different from saying nothing exists. We surface this distinction deliberately: the Distil checker tells you when we have explicitly assessed a pair and when we have not, because both are useful information. If you take Canagliflozin alongside a supplement, the checker below will surface anything already in our database, and the missing-item form at the bottom of the page routes uncatalogued pairs into our next curation pass.
What this list does not say. Pairs not flagged here are not implicitly safe. They are either not yet in our database, or fall outside our inclusion scope (food-supplement interactions only; for drug-drug interactions, the BNF is authoritative). Use the checker below to surface any supplement, and submit a missing item if you take something we have not catalogued.
No affiliates. No commission. We earn nothing on what you buy.
How we grade severity, choose what's in scope, and what we exclude.
Every call on this page is reasoned. We publish the full rubric for severity tiers, the medication inclusion logic, the evidence grades we accept, and what we deliberately leave out. About three thousand words. Worth reading once if you use this tool more than occasionally.
Read the full methodologyA full supplement review, built around you, not a generic stack.
The free checker answers one interaction question at a time. A Distil report reviews the bigger picture: your goals, diet, medications, current supplements and any blood results you provide, then shows what appears worth keeping, changing, adding or leaving out.
- what your diet already covers, so you are not adding a capsule for something food is already handling
- which evidence-graded compounds are worth considering for your goals, and which were considered but left out
- what to keep, change or stop from what you already take, plus the order to introduce anything new
- how your medications and complete supplement stack fit together, with daily timing and a clear point for reassessment
The interaction check is one section of the full report. You also get the reasoning behind each recommendation and the evidence references used.
£49 introductory price for early customers. Standard price £79.
Something missing?
If a supplement or medication you take isn't in our autocomplete, tell us. We go through what people flag every week and add what's missing.